REPLY
20.12.2023 09:31:34 CET | Business Wire | Press release
Concept Reply, part of the Reply network of companies and specialised in IoT, is working with MULTIVAC, a leading manufacturer of processing and packaging solutions, to develop smart services for automated machine monitoring. This project is part of the Open Industry 4.0 Alliance initiative, in which industry-specific companies have joined forces to develop common standards for the transformation to the Industrial Internet of Things.
As a member of the Open Industry 4.0 Alliance, Concept Reply contributes its expertise to IoT projects and actively supports the setting of standards in the field of Industrial IoT. In this context, Concept Reply is successfully working for international founding member MULTIVAC on the "smart services" project. This cloud IoT project aims to digitally manage machines - both locally and remotely - to make processes more transparent and to increase the efficiency and productivity of systems.
The cloud IoT platform implemented for MULTIVAC acts as a central monitoring and management instance. The data is processed on the platform and made available to users as smart services in freely configurable dashboards. The use of a micro-front-end architecture on the Azure cloud and the application of modern web technologies form the basis for the future use of AI-based assistants, thus laying the foundation for new business models and a sustainable, resource-efficient smart factory. The combination of cloud & edge computing reduces latency from data acquisition to sensor technology and actuator control. The benefits for the user are real-time data processing, protection against cyber-attacks and direct machine-to-machine communication.
Further projects with MULTIVAC are already in the pipeline to expand industry standards through the intelligent digitalisation of production and to actively shape the future of Industry 4.0. Dr Marius Grathwohl, VP Digital Products and Transformation at MULTIVAC and Member of the Board of the Alliance, concluded: "The successful collaboration between Concept Reply and MULTIVAC is based on the commonality of an open mindset and a shared understanding of Industry 4.0. Both companies are members of the Open Industry 4.0 Alliance, and we already have a common understanding of the architecture".
Together with its members, the Open Industry 4.0 Alliance is developing multi-vendor Industry 4.0 solutions and services for automated production systems and warehouses. Use cases include automated onboarding, device provisioning, device management, digital nameplates, digital twins and automated device lifecycle management. The open technical ecosystems enable machines and applications from different vendors to be networked and data to be securely transported along the value chain.
Reply
Reply [EXM, STAR: REY] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
Concept Reply
Concept Reply is an IoT software developer specializing in the research, development and validation of innovative solutions and supports its customers in the automotive, manufacturing, smart infrastructure and other industries in all matters relating to the Internet of Things (IoT) and cloud computing. The goal is to offer end-to-end solutions along the entire value chain: from the definition of an IoT strategy, through testing and quality assurance, to the implementation of a concrete solution. www.concept.reply.com
MULTIVAC Group
Bundled expertise, innovative top technology and strong brands under one roof: The MULTIVAC Group offers complete solutions for the packaging and processing of food, medical and pharmaceutical products as well as industrial goods - and continues to set new standards in the market as a technology leader. For more than 60 years, the name has stood for stability and values, innovation and sustainability, quality and excellent service. Founded in 1961 in the Allgäu region of Germany, the MULTIVAC Group is now a global solutions provider that helps small and medium-sized companies as well as large corporations to organise their production processes efficiently and in a way that conserves resources. www.multivac.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231220017040/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom